Sharing Vaccine Expertise

BioNet is a leading innovator in the field of genetically designed vaccines against pertussis and other infectious diseases, using cutting-edge technologies.

BioNet is based in both Europe and Asia and has teams located in the US and Australia. We foster collaborations to advance innovation and deliver vaccines against re-emerging and pandemic diseases.

3

licensed
recombinant pertussis vaccines

200+

collaborators
sharing their passion for vaccines

30+

years’ experience
in international management

20+

clinical trials experience

10+

mRNA
candidates

Vision

To become a leading biotech organization Sharing innovation and expertise to enable Access to vaccines anywhere in the world.

Mission

“A world free any preventable disease is our dream. To make this dream come true is our mission”

Committed to Excellence

BioNet commits to develop and manufacture innovative high-quality vaccines that comply with applicable regulatory requirements. BioNet aims to integrate quality beyond compliance in both products and processes through continuous improvement of our quality system.

Our vaccines are manufactured in accordance to Good Manufacturing Practices (GMP) PIC/S standards, and tested at each manufacturing step as per pharmacopeia requirements in our own quality control and testing facilities.